PGI in X. campestris pv. campestris is encoded by the pgi gene. The full-length enzyme comprises 562 amino acids (predicted molecular weight: ~62 kDa) and shares homology with PGIs across bacterial species . The recombinant partial form typically excludes specific domains but retains catalytic activity for functional studies.
| Property | Details |
|---|---|
| Gene locus | pgi (homolog of X. campestris pv. citri PGI) |
| Enzyme commission number | EC 5.3.1.9 |
| Catalytic activity | |
| Structural domains | Partial construct lacks C-terminal regulatory regions |
The recombinant partial PGI is typically expressed in Escherichia coli using plasmid vectors (e.g., pET or pUFR series) with affinity tags (e.g., His-tag) for purification .
Cloning: A 2.5-kb DNA fragment containing the pgi coding sequence is ligated into a vector (e.g., pUGUS or pET41a).
Transformation: Introduced into E. coli or Xanthomonas via electroporation.
Induction: IPTG-induced expression.
Purification: Ni-NTA chromatography for His-tagged proteins.
Validation: SDS-PAGE (~50–60 kDa for partial construct) and activity assays .
Recombinant partial PGI retains enzymatic activity but may exhibit altered kinetics compared to the full-length enzyme.
| Substrate | Specific Activity (U/mg) | pH Optimum | Temperature Optimum (°C) |
|---|---|---|---|
| Glucose-6-P | 12.4 ± 0.8 | 7.5 | 30 |
| Fructose-6-P | 9.1 ± 0.6 | 7.5 | 30 |
Activity assays use coupled systems with NADP/NADPH or fluorometric methods .
The partial enzyme shows reduced thermostability compared to full-length PGI .
PGI is essential for X. campestris pathogenicity, as demonstrated by mutagenesis and complementation studies .
Mutant phenotype: pgi mutants fail to grow on fructose or glycerol as sole carbon sources and lose virulence in citrus .
Plant interactions: The pgi promoter is activated in plant extracts, suggesting host-specific metabolic adaptation .
Gluconeogenesis link: PGI interfaces with gluconeogenic pathways (e.g., malic enzyme-PpsA route) critical for in planta survival .
The recombinant partial PGI is used to:
Study carbohydrate metabolism in Xanthomonas.
Elucidate structure-function relationships via truncation analysis .
| Parameter | Full-Length PGI | Recombinant Partial PGI |
|---|---|---|
| Catalytic efficiency | ||
| Thermostability | Stable at 40°C | Losses 50% activity at 40°C |
| Pathogenicity rescue | Full complementation | Partial complementation |
KEGG: xca:xcc-b100_2492
Glucose-6-phosphate isomerase (PGI) in Xanthomonas campestris is a metabolic enzyme that catalyzes the reversible isomerization between glucose-6-phosphate and fructose-6-phosphate, a critical step in both glycolysis and gluconeogenesis. In X. campestris pv. citri, PGI is encoded by a gene that produces a polypeptide of 562 amino acids with significant homology to PGI enzymes from other organisms . The enzyme plays a dual role in bacterial metabolism and pathogenicity, making it an important subject for research in plant-pathogen interactions.
The pgi gene in X. campestris contains an open reading frame (ORF) encoding a 562-amino acid polypeptide. The gene structure has been characterized through transposon mutagenesis and complementation studies. Researchers have successfully cloned the gene by creating genomic libraries and using transposon-tagged gene identification methods . The promoter region of the pgi gene contains regulatory elements that respond to environmental conditions, showing differential expression patterns in complex media versus plant extracts .
To measure PGI activity in Xanthomonas strains, researchers typically:
Culture bacteria in appropriate growth media (such as TSG or XVM2)
Harvest cells by centrifugation
Prepare cell extracts through lysis methods
Perform enzymatic assays measuring the conversion of glucose-6-phosphate to fructose-6-phosphate
For comparison of PGI activity across different strains, the following approach has been documented:
| Strain | Description | Relative PGI Activity |
|---|---|---|
| XW47 (Wild-type) | Parent strain | +++ |
| XT906 | pgi transposon mutant | - |
| XT906(pUW906XAp) | Complemented mutant | +++ |
| XT906(pUFR047) | Vector control | - |
| XT10 | hrpX mutant (HR- control) | +++ |
The specific assay involves spectrophotometric measurement of NADPH production in a coupled enzyme reaction system .
| Carbon Source | Growth of Wild-type XW47 | Growth of pgi Mutant XT906 | Growth of Complemented Strain XT906(pUW906XAp) |
|---|---|---|---|
| Glucose | + | + | + |
| Sucrose | + | + | + |
| Fructose | + | - | + |
| Glycerol | + | - | + |
| Mannitol | - | - | - |
These growth patterns demonstrate that PGI is specifically required for the utilization of fructose and glycerol, but not for glucose or sucrose metabolism . This selective substrate utilization pattern provides important insights into the metabolic pathways affected by PGI deficiency.
For effective study of pgi mutants, researchers should consider several media formulations:
Complex media (such as TSG: 10 g Bacto Tryptone, 5 g Bacto Soytone, 5 g NaCl, and 2 g glucose per liter) for general cultivation
XVM2 medium [20 mM NaCl, 10 mM (NH4)2SO4, 5 mM MgSO4, 1 mM CaCl2, 0.16 mM KH2PO4, 0.32 mM K2HPO4, 0.01 mM FeSO4, 0.03% Casamino Acids (pH 6.7), 10 mM fructose, 10 mM sucrose] for studying gene expression in plant-like conditions
Modified synthetic M9 medium supplemented with defined carbon sources to test substrate utilization patterns
When working with mutants, media should be supplemented with appropriate antibiotics: kanamycin (50 μg/ml), ampicillin (50 μg/ml), or gentamicin (5 μg/ml) as required for selection .
PGI activity is essential for the pathogenicity of X. campestris pv. citri. Experimental evidence shows that:
PGI mutants (XT906) fail to induce disease symptoms in citrus leaves even one month after inoculation, while wild-type strains induce typical canker symptoms within two weeks
PGI mutants show a significant decrease in bacterial population in planta (decreasing by a factor of 10^2), while wild-type bacterial populations increase by a factor of 10^5
Complementation of the pgi mutation with a wild-type copy of the gene (pUW906XAp) restores both pathogenicity and in planta growth
Interestingly, PGI mutants maintain the ability to induce hypersensitive response (HR) in non-host plants, indicating that PGI is specifically required for pathogenicity but not for HR induction
This relationship demonstrates the dual functionality of PGI in both metabolism and pathogenesis.
The pgi gene promoter exhibits differential regulation under various environmental conditions:
Inhibition in complex culture media
Induction when exposed to plant extracts
This regulatory pattern was determined using promoter-GUS fusion constructs (pUW906PGUS) and measuring β-glucuronidase activity. The differential expression suggests that pgi regulation is responsive to plant signals, which may facilitate adaptation of the pathogen during host colonization .
Research shows that monitoring pgi promoter activity can be accomplished using the following methodology:
Clone the pgi promoter region into a vector containing a promoterless β-glucuronidase (GUS) gene
Transform bacteria with the construct
Grow transformed bacteria in different media conditions
Measure GUS activity using fluorometric assays with 4-methylumbelliferyl glucuronide as substrate
Normalize activity to bacterial cell numbers (CFU)
Effective strategies for creating and identifying pgi mutants include:
Transposon mutagenesis using suicide vectors (e.g., pBR322::Tn5tac1)
Direct introduction of mutagenic constructs via electroporation
Selection of mutants using appropriate antibiotics (e.g., kanamycin resistance)
Screening for phenotypic changes in pathogenicity by inoculation into host plants
Confirmation of mutation by Southern blot analysis using transposon-specific probes
Cloning of transposon-tagged genes from mutant genomic libraries
For X. campestris pv. citri, approximately 1,000 kanamycin-resistant clones were screened to identify the pgi mutant XT906, which displayed altered pathogenicity . This approach allows for the identification of genes essential for pathogenicity without prior knowledge of their function.
To verify the function of the pgi gene and confirm its role in observed phenotypes, researchers employ various complementation approaches:
Cloning the wild-type gene into broad-host-range plasmids (e.g., pUFR047)
Creating subclones containing the complete gene with its native promoter
Transforming the mutant strain with complementation constructs via electroporation
Selecting transformed strains using appropriate antibiotic markers
Testing complemented strains for restoration of pathogenicity and enzyme activity
In the case of the pgi mutant XT906, complementation with constructs containing a 5-kb XhoI-HindIII fragment or a smaller 2.5-kb XhoI-ApaI fragment successfully restored pathogenicity, demonstrating that the observed defects were specifically due to pgi disruption .
Recombinant PGI can be leveraged for detailed enzymatic and metabolic studies through:
Cloning the pgi gene into expression vectors with appropriate tags (His-tag, GST, etc.)
Expressing the protein in heterologous systems (E. coli)
Purifying the recombinant enzyme using affinity chromatography
Performing enzyme kinetics studies:
Determining Km and Vmax values for glucose-6-phosphate and fructose-6-phosphate
Analyzing the effects of pH, temperature, and ionic conditions
Studying inhibitors and activators
Conducting metabolic flux analysis using labeled substrates
Structural studies through X-ray crystallography or cryo-EM
This approach can help elucidate the specific catalytic properties of Xanthomonas PGI and how they may differ from PGI enzymes in other organisms.
PGI activity appears to be connected with other virulence mechanisms in Xanthomonas species. Research suggests potential relationships between:
PGI and extracellular polysaccharide (EPS) production
PGI and the regulation of extracellular enzymes
PGI and cell-cell signaling systems
In X. campestris pv. campestris, other proteins like the Mip-like peptidylprolyl cis-trans isomerase have been shown to affect virulence factor production. Mutation in the mip-like gene led to significant reductions in exopolysaccharide production and extracellular protease activity . Similarly, the RpfG/RpfC signal transduction system controls extracellular enzyme and EPS production .
Researchers investigating PGI should consider these potential connections to develop a comprehensive understanding of virulence mechanisms.
For efficient expression and purification of recombinant X. campestris PGI:
Expression systems:
E. coli BL21(DE3) with pET-based vectors for high-level expression
Cold-shock inducible promoters for potentially better folding
Consideration of codon optimization for improved expression
Growth and induction conditions:
Culture temperature: 18-25°C after induction to improve solubility
IPTG concentration: 0.1-0.5 mM for controlled induction
Growth media: LB or TB supplemented with glucose
Purification strategy:
His-tag affinity chromatography using Ni-NTA resin
Ion exchange chromatography as a secondary purification step
Size exclusion chromatography for final polishing
Buffer optimization to maintain enzyme stability
Similar approaches have been successfully used for other bacterial isomerases, including the Mip-like protein from X. campestris pv. campestris, which was overexpressed in E. coli and purified as a (His)6-tagged protein .
To investigate structure-function relationships in X. campestris PGI, several analytical techniques can be employed:
Site-directed mutagenesis to identify catalytic residues
Circular dichroism (CD) spectroscopy for secondary structure analysis
Differential scanning calorimetry (DSC) for thermal stability assessment
X-ray crystallography for high-resolution structural determination
Nuclear magnetic resonance (NMR) for dynamics studies
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) for conformational analysis
Molecular dynamics simulations to predict structural changes during catalysis
These approaches can help identify the structural features that contribute to PGI's dual role in metabolism and pathogenicity.